BillionToOne, Inc. (BLLN) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated Jun 12, 2026
Current Price
$101.12
Price Target
$125.00
Target Range
$120.00 — $130.00
Analyst Rating
Buy
Forward P/E102.7x
Trailing P/E1587.4x
Forward PEG—
Implied Growth+107.1%
Median Target$125.00
Analyst Spread8.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$120
+18.7%
Consensus
$125
+23.6%
Bull Case
$130
+28.6%
BLLN Price Target Analysis
Updated June 13, 2026As of June 13, 2026, BillionToOne, Inc. (BLLN) has a Wall Street consensus price target of $125.00, based on estimates from 4 covering analysts. With the stock currently trading at $101.12, this represents a potential upside of +23.6%. The company has a market capitalization of $4.65B.
Analyst price targets range from a low of $120.00 to a high of $130.00, representing a 8% spread in expectations. The median target of $125.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BLLN trades at a trailing P/E of 1587.4x and forward P/E of 102.7x. Analysts expect EPS to grow +107.1% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+60.9%
Avg Forward P/E103.0x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NTRANatera, Inc. | $30.4B | $212.07 | $261.00 | +23.1% | Buy | — | 27 |
 ILMNIllumina, Inc. | $24.5B | $160.97 | $151.40 | -5.9% | Buy | 30.8x | 50 |
 PGNYProgyny, Inc. | $2.1B | $26.63 | $30.33 | +13.9% | Buy | 20.8x | 20 |
 CDNACareDx, Inc | $1.2B | $22.97 | $24.00 | +4.5% | Buy | 24.6x | 13 |
 EXASExact Sciences Corporation | $20.0B | $104.91 | $105.00 | +0.1% | Buy | 582.8x | 41 |
 PACBPacific Biosciences of California, Inc. | $407M | $1.31 | $1.00 | -23.7% | Buy | — | 18 |
 PRMEPrime Medicine, Inc. | $501M | $2.77 | $17.25 | +521.6% | Buy | — | 9 |
 TMOThermo Fisher Scientific Inc. | $174.4B | $469.34 | $599.70 | +27.8% | Buy | 18.9x | 42 |
 DHRDanaher Corporation | $127.5B | $180.10 | $231.80 | +28.7% | Buy | 21.3x | 43 |
 AAgilent Technologies, Inc. | $36.7B | $129.84 | $154.75 | +19.2% | Buy | 21.4x | 40 |
Upside Potential Comparison
PRMEDHRTMONTRAAPGNYCDNAEXASWhat if you invested $1,000 in BLLN 10 years ago?
Total return calculator · dividends reinvested
Calculate ReturnsHow much would $100/month in BLLN be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs BLLN Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationHow does BLLN stack up against peers?
Compare business quality, growth, and profitability against top sector peers.
Compare NowBLLN — Frequently Asked Questions
Quick answers to the most common questions about buying BLLN stock.
What is the BLLN stock price target for 2026?
The consensus Wall Street price target for BLLN is $125, representing 23.6% upside from the current price of $101.12. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is BLLN a buy, sell, or hold?
BLLN has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $125 implies 23.6% upside from current levels.
Is BLLN stock overvalued or undervalued?
At a forward P/E of 102.7225x, BLLN trades at a premium valuation. The consensus price target of $125 (23.6% upside) suggests analysts still see growth justifying the multiple.
How high can BLLN stock go?
The most bullish Wall Street analyst has a price target of $130 for BLLN, while the most conservative target is $120. The consensus of $125 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover BLLN stock?
BLLN is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BLLN stock forecast?
The 12-month BLLN stock forecast based on 4 Wall Street analysts shows a consensus price target of $125, with estimates ranging from $120 (bear case) to $130 (bull case). The median consensus rating is "Buy".
What is BLLN's forward P/E ratio?
BLLN trades at a forward P/E ratio of 102.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 1587.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BLLN stock?
Wall Street analysts are very optimistic on BLLN, with a "Buy" consensus rating and $125 price target (23.6% upside). 3 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BLLN price targets vary so much?
BLLN analyst price targets range from $120 to $130, a 8% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $125 consensus represents the middle ground.